Items tagged with "MAT"


articles  |   Addressing Opioid Use Disorders in Community Corrections: A Survey of Illinois Probation Departments

Published: October 26, 2018
Nearly one-third of Illinois probationers suffer from an opioid use disorder (OUD). Despite evidence that FDA-approved medications—methadone, buprenorphine, and naltrexone—can effectively treat OUD, many probation departments do not allow their clients to use them, even when prescribed by a healthcare provider. ICJIA researchers surveyed probation departments across the state to better understand their familiarity with, and training on, the medications, as well as barriers to their clients’ access and use. This article summarizes the study’s findings.



publications  |   Addressing Opioid Use Disorders in Community Corrections: A Survey of Illinois Probation Departments

Published: October 26, 2018
Nearly one-third of Illinois probationers suffer from an opioid use disorder (OUD). Despite evidence that FDA-approved medications—methadone, buprenorphine, and naltrexone—can effectively treat OUD, many probation departments do not allow their clients to use them, even when prescribed by a healthcare provider. ICJIA researchers surveyed probation departments across the state to better understand their familiarity with, and training on, the medications, as well as barriers to their clients’ access and use. This article summarizes the study’s findings.



publications  |   Addressing Opioid Use Disorders in Corrections: A Survey of Illinois Jails

Published: September 7, 2018
Even with substantial efforts at the state and local levels, opioid overdoses in Illinois continue to rise. Many in jails and prisons suffer from opioid use disorders and some receive treatment. Upon release, the risk of overdose is enhanced due to reduced tolerance. This article presents findings from a survey of 36 Illinois jail administrators on the use of medication-assisted treatment for detainees with opioid use disorders, naloxone distribution to reduce post-release overdose, and policies to ensure safe withdrawal from opioids and other drugs.



articles  |   Addressing Opioid Use Disorders in Corrections: A Survey of Illinois Jails

Published: September 7, 2018
Even with substantial efforts at the state and local levels, opioid overdoses in Illinois continue to rise. Many in jails and prisons suffer from opioid use disorders and some receive treatment. Upon release, the risk of overdose is enhanced due to reduced tolerance. This article presents findings from a survey of 36 Illinois jail administrators on the use of medication-assisted treatment for detainees with opioid use disorders, naloxone distribution to reduce post-release overdose, and policies to ensure safe withdrawal from opioids and other drugs.



publications  |   An Overview of Medication- Assisted Treatment for Opioid Use Disorders for Criminal Justice-Involved Individuals

Published: July 24, 2017
There is a national opioid epidemic and one intervention to help those suffering from an opioid use disorder (OUD) is medication-assisted treatment (MAT). MAT is the use of medications in conjunction with behavioral therapy as part of a long-term treatment regimen. There are three main MAT medications used today—methadone, buprenorphine, and naltrexone. Research has shown MAT, in particular the use of methadone or buprenorphine, is considered an evidence-based practice to treat OUD. Studies indicate those in MAT have better outcomes than those who engage in therapy alone. This article provides an overview of MAT with a focus on use with criminal justice populations.



articles  |   An Overview of Medication-Assisted Treatment for Opioid Use Disorders for Criminal Justice-Involved Individuals

Published: July 18, 2017
There is a national opioid epidemic and one intervention to help those suffering from an opioid use disorder (OUD) is medication-assisted treatment (MAT). MAT is the use of medications in conjunction with behavioral therapy as part of a long-term treatment regimen. There are three main MAT medications used today—methadone, buprenorphine, and naltrexone. Research has shown MAT, in particular the use of methadone or buprenorphine, is considered an evidence-based practice to treat OUD. Studies indicate those in MAT have better outcomes than those who engage in therapy alone. This article provides an overview of MAT with a focus on use with criminal justice populations.